AI appeals overturn 80% of insurance denials as insurtech automates patient advocacy
U.S. startup Claimable deploys AI to reverse denied health insurance claims, achieving over 80% success rates as the insurtech sector weaponizes automation for patients. The development signals a shift where AI empowers consumers against algorithmic denials, with 1 in 5 insured U.S. adults facing claim rejections yet fewer than 1% filing appeals.
Claimable, founded in 2023 by physician Warris Bokhari, raised $10 million backed by Mark Cuban to automate appeals for 85+ medications across conditions including migraines and rheumatology. The platform charges $50 per case and reports most resolutions within 10 days, targeting a market where insurers uphold original denial decisions more than half the time when appeals are filed.
The company faces competition from Counterforce Health, which offers free appeals while copying regulators on denial patterns. Both players address a structural inefficiency: U.S. insurers increasingly deploy AI to accelerate denials, while patients lack resources to contest decisions at scale.
“The direct-to-consumer model alone doesn’t work at scale. The enterprise channel is where volume becomes viable.”
— Undisclosed investor quoted in source material
Analysis: This admission reveals the economic reality of healthcare AI—consumer-facing plays struggle without institutional partnerships. Claimable’s pivot toward enterprise deals with pharmaceutical manufacturers and hospital systems indicates the real revenue lies in B2B distribution, not individual patients.
Why this matters
MENA’s insurance infrastructure faces parallel challenges. Saudi Arabia reports 15%-25% claims rejection rates, with the Kingdom’s AI claims automation market reaching $1.2 billion in 2024. UAE-based Klaim raised $26 million to compress claim cycles from 60-90 days to 24 hours, demonstrating regional appetite for automation-driven efficiency.
The arms race dynamic—AI accelerating both denials and appeals—creates opportunity for MENA fintechs under Vision 2030 digitization mandates. Saudi Arabia’s SAMA and UAE’s CBUAE face regulatory questions as algorithms determine healthcare access. Will regulators mandate explainability standards for AI-driven denials? Enterprise healthcare partnerships offer MENA insurtech players a proven monetization path beyond direct-to-consumer models.
What’s next
Regulatory frameworks emerging from SAMA and CBUAE regarding AI-driven claims processing, and whether regional insurers adopt similar appeal automation to manage disputes at scale.
Conclusion
U.S. developments establish the technical playbook for MENA fintech to address claims friction, positioning AI-powered dispute resolution as infrastructure for the region’s healthcare digitization trajectory.
Sources: PYMNTS, Claimable, Ken Research, MENAbytes, Glance
